ArticleOncoTargets and therapy2018

CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway.

Fu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.